Buy Rating Affirmed for AIM ImmunoTech Amidst Promising Trials and Product Pipeline Developments
TipRanksFeb 15 13:45 ET
Strong Financial Position and Promising Clinical Trials Bolster Buy Rating for AIM ImmunoTech: An Analysis by Jason McCarthy
TipRanksNov 16, 2023 12:06 ET
Analysts Are Bullish on These Healthcare Stocks: AIM ImmunoTech (AIM), Microbot Medical (MBOT)
TipRanksAug 17, 2023 12:30 ET
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and AIM ImmunoTech (AIM)
TipRanksMay 18, 2023 15:00 ET
Ascendiant Remains a Buy on AIM ImmunoTech (AIM)
TipRanksApr 7, 2023 04:20 ET
Maxim Group Sticks to Their Buy Rating for AIM ImmunoTech (AIM)
TipRanksApr 5, 2023 07:25 ET
AIM ImmunoTech (AIM) Receives a Buy From Maxim Group
TipRanksMar 1, 2023 14:31 ET
Maxim Group Keeps Their Buy Rating on AIM ImmunoTech (AIM)
TipRanksSep 1, 2022 07:50 ET
Maxim Group Sticks to Its Buy Rating for AIM ImmunoTech (AIM)
TipRanksAug 16, 2022 14:20 ET
No Data
No Data